Chemoprevention is presumably one of most effective means to combat
prostate cancer (PCa). Patients usually require more than a decade to develop a
clinically significant PCa, therefore, an ideal target for chemoprevention. This review
will focus on recent findings of a group of naturally occurring chemicals, carotenoids,
for potential use in reducing PCa risk.
Keywords: Antioxidant, cancer risk, carotene, carotenoids, chemoprevention,
prostate cancer, retinoids, lycopene.
